AIG
LYEL icon

American International Group’s Lyell Immunopharma LYEL Stock Holding History

American International Group’s Portfolio LYEL Stock Details LYEL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-4,276
Closed -$191K – 1548
2024
Q1 		$191K Sell
4,276
-37
-0.9% -$1.58K ﹤0.01% 2171
2023
Q4 		$167K Sell
4,313
-17
-0.4% -$612 ﹤0.01% 2259
2023
Q3 		$127K Buy
4,330
+154
+4% +$7.31K ﹤0.01% 2371
2023
Q2 		$266K Buy
4,176
+1
+0% +$55 ﹤0.01% 2015
2023
Q1 		$197K Buy
4,175
+83
+2% +$4.44K ﹤0.01% 2115
2022
Q4 		$284K Sell
4,092
-15
-0.4% -$1.49K ﹤0.01% 1930
2022
Q3 		$602K Buy
4,107
+58
+1% +$7.85K ﹤0.01% 1464
2022
Q2 		$528K Buy
4,049
+367
+10% +$37.5K ﹤0.01% 1566
2022
Q1 		$372K Buy
3,682
+3,054
+486% +$370K ﹤0.01% 1891
2021
Q4 		$97K Sell
628
-19
-3% -$4.24K ﹤0.01% 2730
2021
Q3 		$191K Buy
+647
New +$194K ﹤0.01% 2455

Other funds holding LYEL

MM
MWG Management Road Town, Tortola, British Virgin Islands $81.3M AUM 2.28% 1-Year Est. Return
OPL
Orland Properties Ltd Road Town, Tortola, British Virgin Islands $202M AUM 2.79% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FCMI
Foresite Capital Management IV Larkspur, California $290M AUM 143.88% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
WA
WuXi AppTec Shanghai, China $19M AUM 20.22% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
AI
Alphabet Inc Mountain View, California $99.1B AUM 124.46% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

American International Group's LYEL Position: Q2 2024 in Review

American International Group sold out of Lyell Immunopharma (LYEL) in Q2 2024, closing a stake of 4,276 shares — an estimated $191K sold.

American International Group first reported a position in LYEL in Q3 2021 and held it in 11 quarters. The position peaked at $602K in Q3 2022. 120 funds tracked by Wall St. Rank hold LYEL as of Q2 2024.

  • American International Group reported no remaining Lyell Immunopharma position as of Q2 2024 after selling out during the quarter.
  • American International Group sold 4,276 Lyell Immunopharma shares in Q2 2024, an estimated $191K.
  • American International Group first reported a position in Lyell Immunopharma in Q3 2021 and held it in 11 quarters.
  • American International Group's Lyell Immunopharma position peaked at $602K in Q3 2022.
  • 120 funds tracked by Wall St. Rank held Lyell Immunopharma as of Q2 2024.

Based on American International Group's 13F filing for Q2 2024, filed 13 Aug 2024.